Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients

NCT01618474 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Stomach Cancer

Interventions

DRUG: DX
DRUG: XELOX

Sponsor

Tianjin Medical University Cancer Institute and Hospital